Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |